Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biorestorative Therapies Inc (BRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,347
  • Shares Outstanding, K 8,070
  • Annual Sales, $ 80 K
  • Annual Income, $ -9,440 K
  • 36-Month Beta 0.42
  • Price/Sales 157.35
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.61
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2900 +18.60%
on 10/11/18
2.9100 -47.42%
on 09/26/18
-0.6400 (-29.49%)
since 09/21/18
3-Month
1.0300 +48.54%
on 08/20/18
4.0000 -61.75%
on 08/02/18
-0.1600 (-9.47%)
since 07/20/18
52-Week
1.0300 +48.54%
on 08/20/18
4.0000 -61.75%
on 08/02/18
-2.1700 (-58.65%)
since 10/20/17

Most Recent Stories

More News
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the appointment of Lance Alstodt as Executive...

BRTX : 1.5300 (-3.16%)
Why This Company is Set for a Major Breakout

HENDERSON, NV / ACCESSWIRE / October 15, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors.

BRTX : 1.5300 (-3.16%)
Cannabis and Biotech Stocks That Are Set to Explode!

HENDERSON, NV / ACCESSWIRE / October 11, 2018 / With the broader market tanking it is likely investors will find safe haven in cannabis and biotech stocks because they are both innovative sectors.

APHQF : 12.0300 (-13.70%)
BRTX : 1.5300 (-3.16%)
VSTM : 5.43 (-3.72%)
TGODF : 3.1500 (-16.45%)
Major Action in Biotech and This is The Next Winner

HENDERSON, NV / ACCESSWIRE / October 5, 2018 / The NASDAQ Biotech Index is up 13% over the past six months. With several large announcements seemingly on the horizon this trend should continue into the...

TRVN : 0.88 (-5.38%)
CLVS : 20.19 (-4.40%)
BRTX : 1.5300 (-3.16%)
PRTK : 8.89 (-1.11%)
BioRestorative Therapies Announces Metabolic Research Collaboration with University of Pennsylvania

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has entered into a one-year...

BRTX : 1.5300 (-3.16%)
Biotech and Cannabis Firms to Watch as Acquisition, Investment, and Licensing Season Begins

FN Media Group Presents Microcapspeculators.com News Commentary

CVSI : 5.1500 (-8.04%)
APHQF : 12.0300 (-13.70%)
TLRY : 106.44 (-13.18%)
XXII : 2.62 (-2.24%)
BRTX : 1.5300 (-3.16%)
BioRestorative Therapies Announces Publication of Study Results Validating the Benefits of Using Hypoxic Cultured Cells to Treat Patients with Degenerative Disc Disease

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Journal of Translational Medicine...

BRTX : 1.5300 (-3.16%)
Stem Cell Companies Innovating for the Future

FN Media Group Presents Microcapspeculators.com News Commentary

SGMO : 12.70 (-2.76%)
BRTX : 1.5300 (-3.16%)
VCEL : 11.29 (-0.35%)
FATE : 11.78 (-15.63%)
ATHX : 2.02 (-0.49%)
BioRestorative Therapies Appoints Wayne J. Olan, M.D. as Clinical Director of Regenerative Disc/Spine Program

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Wayne J. Olan, M.D. has been appointed...

BRTX : 1.5300 (-3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BRTX with:

Key Turning Points

2nd Resistance Point 1.9433
1st Resistance Point 1.7367
Last Price 1.5300
1st Support Level 1.3367
2nd Support Level 1.1433

See More

52-Week High 4.0000
Fibonacci 61.8% 2.8655
Fibonacci 50% 2.5150
Fibonacci 38.2% 2.1645
Last Price 1.5300
52-Week Low 1.0300

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar